JETIREXPLORE- Search Thousands of research papers



Published in:

Volume 5 Issue 6
June-2018
eISSN: 2349-5162

Unique Identifier

JETIR1806729

Page Number

230-234

Share This Article


Title

IDIC Model in Pharmaceutical Companies

ISSN

2349-5162

Cite This Article

"IDIC Model in Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 6, page no.230-234, June-2018, Available :http://www.jetir.org/papers/JETIR1806729.pdf

Abstract

The Indian pharmaceutical market is a very uneven market and does not Veronese product patent. Hence brand differentiation is very complex in a market where there are over 50 brands for every molecule. Thus the relationship between the Medical Representative (the main medium of promotion) and the doctor is the key driver for sales. A complete step by step process is given to beginning a CRM initiative based on the IDIC model recommended by peppers and Rogers.

Key Words

Marketing, Management, Customer, Patent.

Cite This Article

"IDIC Model in Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 6, page no. pp230-234, June-2018, Available at : http://www.jetir.org/papers/JETIR1806729.pdf

Publication Details

Published Paper ID: JETIR1806729
Registration ID: 184416
Published In: Volume 5 | Issue 6 | Year June-2018
DOI (Digital Object Identifier):
Page No: 230-234
ISSN Number: 2349-5162

Download Paper

Preview Article

Download Paper




Cite This Article

"IDIC Model in Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 6, page no. pp230-234, June-2018, Available at : http://www.jetir.org/papers/JETIR1806729.pdf




Preview This Article


Downlaod

Click here for Article Preview